|

Jelmyto (mitomycin) for pyelocalyceal solution Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Jelmyto, UGN-101

Top Sponsors

  • UroGen Pharma Ltd.1

Indications

  • Transitional Cell Carcinoma of Renal Pelvis1
  • Carcinoma, Transitional Cell1
  • Urothelial Carcinoma of the Renal Pelvis and Ureter1
  • Urothelial Carcinoma Ureter Recurrent1
  • Urothelial Carcinoma Recurrent1

Santa Monica, California1 trial

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Providence St. Johns Health Center

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.